Cargando…

Autocrine activin A signalling in ovarian cancer cells regulates secretion of interleukin 6, autophagy, and cachexia

BACKGROUND: The majority of patients with advanced cancer develop cachexia, a weight loss syndrome that severely reduces quality of life and limits survival. Our understanding of the underlying mechanisms that cause the condition is limited, and there are currently no treatment options that can comp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pettersen, Kristine, Andersen, Sonja, van der Veen, Anna, Nonstad, Unni, Hatakeyama, Shinji, Lambert, Christian, Lach‐Trifilieff, Estelle, Moestue, Siver, Kim, Jana, Grønberg, Bjørn Henning, Schilb, Alain, Jacobi, Carsten, Bjørkøy, Geir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015233/ https://www.ncbi.nlm.nih.gov/pubmed/31436048 http://dx.doi.org/10.1002/jcsm.12489

Ejemplares similares

Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling
por: Pettersen, Kristine, et al.
Publicado: (2017)

ActRII blockade protects mice from cancer cachexia and prolongs survival in the presence of anti-cancer treatments
por: Hatakeyama, Shinji, et al.
Publicado: (2016)

Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy
por: Morvan, Frederic, et al.
Publicado: (2017)

Discovery of a new marker to identify myeloid cells associated with metastatic breast tumours
por: Bokil, Ansooya A., et al.
Publicado: (2023)

An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastoma
por: Morabito, Morgane, et al.
Publicado: (2019)

Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer
por: Moestue, Siver A, et al.
Publicado: (2013)

Activin A is a prominent autocrine regulator of hepatocyte growth arrest
por: Haridoss, Srividyameena, et al.
Publicado: (2017)

Comprehensive proteome analysis of human skeletal muscle in cachexia and sarcopenia: a pilot study
por: Ebhardt, H. Alexander, et al.
Publicado: (2017)

The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy
por: Zhong, Xiaoling, et al.
Publicado: (2019)

Clinical Classification of Cancer Cachexia: Phenotypic Correlates in Human Skeletal Muscle
por: Johns, Neil, et al.
Publicado: (2014)

Intravascular Targets for Molecular Contrast-Enhanced Ultrasound Imaging
por: Moestue, Siver A., et al.
Publicado: (2012)

Activin-β(C) modulates cachexia by repressing the ubiquitin-proteasome and autophagic degradation pathways
por: Marino, Francesco Elia, et al.
Publicado: (2015)

Impairment of the activin A autocrine loop by lopinavir reduces self-renewal of distinct human adipose progenitors
por: Ravaud, Christophe, et al.
Publicado: (2017)

The marine n-3 PUFA DHA evokes cytoprotection against oxidative stress and protein misfolding by inducing autophagy and NFE2L2 in human retinal pigment epithelial cells
por: Johansson, Ida, et al.
Publicado: (2015)

Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wasting
por: Levolger, S., et al.
Publicado: (2019)

Treatment with Soluble Activin Receptor Type IIB Alters Metabolic Response in Chemotherapy-Induced Cachexia
por: O’Connell, Thomas M., et al.
Publicado: (2019)

Visceral adipose tissue remodeling in pancreatic ductal adenocarcinoma cachexia: the role of activin A signaling
por: Xu, Pauline C., et al.
Publicado: (2022)

Activin A Plays a Critical Role in Adipose Tissue Wasting in the Progression of Cancer Cachexia
por: Luan, Yi, et al.
Publicado: (2021)

Pancreatic Ductal Adenocarcinoma Highly Expresses Activin A: Implications in Adipose Tissue and Cancer Cachexia
por: Xu, Pauline, et al.
Publicado: (2021)

Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin
por: Zhong, Xiaoling, et al.
Publicado: (2022)

Somatic cell fate maintenance in mouse fetal testes via autocrine/paracrine action of AMH and activin B
por: Rodriguez, Karina F., et al.
Publicado: (2022)

Genomic Profiling Reveals That Transient Adipogenic Activation Is a Hallmark of Mouse Models of Skeletal Muscle Regeneration
por: Lukjanenko, Laura, et al.
Publicado: (2013)

MRI reveals the in vivo cellular and vascular response to BEZ235 in ovarian cancer xenografts with different PI3-kinase pathway activity
por: Cebulla, J, et al.
Publicado: (2015)

R2* Relaxation Affects Pharmacokinetic Analysis of Dynamic Contrast-Enhanced MRI in Cancer and Underestimates Treatment Response at 7 T
por: Kim, Jana, et al.
Publicado: (2019)

Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors
por: Olsen, Oddrun Elise, et al.
Publicado: (2020)

Identification of BMP and Activin Membrane-Bound Inhibitor (BAMBI) as a Potent Negative Regulator of Adipogenesis and Modulator of Autocrine/Paracrine Adipogenic Factors
por: Luo, Xiao, et al.
Publicado: (2012)

Muscle NAD(+) depletion and Serpina3n as molecular determinants of murine cancer cachexia—the effects of blocking myostatin and activins
por: Hulmi, J.J., et al.
Publicado: (2020)

Autophagy turns specific: the discovery of p62 and NBR1 as autophagy cargo receptors
por: Bjørkøy, Geir
Publicado: (2010)

THU507 Tumor Activin A Mediates Cachexia Primarily Through White Adipose Tissue Hydrolysis In Pancreatic Ductal Adenocarcinoma
por: Yu, Seok-Yeong, et al.
Publicado: (2023)

Opposite and dynamic regulation of the interferon response in metastatic and non-metastatic breast cancer
por: Lamsal, Apsana, et al.
Publicado: (2023)

Activin A Levels Are Associated With Abnormal Glucose Regulation in Patients With Myocardial Infarction: Potential Counteracting Effects of Activin A on Inflammation
por: Andersen, Geir Ø., et al.
Publicado: (2011)

Identification of Metastasis-Associated Metabolic Profiles of Tumors by (1)H-HR-MAS-MRS()()()
por: Gorad, Saurabh S., et al.
Publicado: (2015)

O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes
por: Barkovskaya, Anna, et al.
Publicado: (2019)

Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells
por: Barkovskaya, Anna, et al.
Publicado: (2020)

Cytosolic Phospholipase A2 Alpha Regulates TLR Signaling and Migration in Metastatic 4T1 Cells
por: Tunset, Hanna Maja, et al.
Publicado: (2019)

Castration-resistant prostate cancer cells are dependent on the high activity of CDK7
por: Pallasaho, Satu, et al.
Publicado: (2022)

Blocking Activin Receptor Ligands Is Not Sufficient to Rescue Cancer-Associated Gut Microbiota—A Role for Gut Microbial Flagellin in Colorectal Cancer and Cachexia?
por: Pekkala, Satu, et al.
Publicado: (2019)

Detection and Differentiation of Breast Cancer Sub-Types using a cPLA2α Activatable Fluorophore
por: Chiorazzo, Michael G., et al.
Publicado: (2019)

Detection of phenotype‐specific therapeutic vulnerabilities in breast cells using a CRISPR loss‐of‐function screen
por: Barkovskaya, Anna, et al.
Publicado: (2021)

Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft
por: Pandya, Abhilash D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l5jkb727g3aggql7890r81qei7